Reports for HYDROCHLOROTHIAZIDE
Ingredient
HYDROCHLOROTHIAZIDE
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACH-OLMESARTAN HCTZ | 40MG 25MG | TABLET | Actual shortage | 2024-05-10 | 2024-05-11 | 227794 |
| AA-AMILZIDE | 5MG 50MG | TABLET | Actual shortage | 2024-05-24 | 2024-06-05 | 228768 |
| LOSARTAN/HCTZ | 12.5MG 100MG | TABLET | Actual shortage | 2024-05-28 | 2024-06-06 | 229003 |
| ACH-OLMESARTAN HCTZ | 12.5MG 20MG | TABLET | Actual shortage | 2024-05-31 | 2024-05-31 | 229347 |
| SANDOZ CANDESARTAN PLUS | 12.5MG 16MG | TABLET | Actual shortage | 2024-06-03 | 2024-06-04 | 229487 |
| IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Actual shortage | 2024-06-06 | 2024-06-06 | 229801 |
| HYDROCHLOROTHIAZIDE | 50MG | TABLET | Actual shortage | 2024-06-06 | 2024-06-06 | 229804 |
| VASERETIC | 25MG 8MG | TABLET | Anticipated shortage | 2024-06-14 | 2024-06-14 | 230533 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-HYDROCHLOROTHIAZIDE | 50MG | TABLET | Discontinued | 2018-09-07 | 2019-02-13 | 60521 |
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-09-07 | 2018-09-15 | 60548 | ||
| APO-LOSARTAN/HCTZ | 12.5MG 100MG | TABLET | Discontinued | 2018-09-07 | 2018-11-02 | 60597 |
| APO-LOSARTAN/HCTZ | 25MG 100MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60600 |
| APO-LOSARTAN/HCTZ | 12.5MG 50MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60603 |
| APO TRIAZIDE | 50MG 25MG | TABLET | Discontinued | 2018-09-08 | 2019-02-13 | 60837 |
| APO-LOSARTAN/HCTZ | 25MG 100MG | TABLET | Discontinued | 2018-09-10 | 2018-12-28 | 60997 |
| TEVA-LISINOPRIL/HCTZ (TYPE P) | 12.5MG 10MG | TABLET | Discontinued | 2018-10-12 | 2018-10-12 | 63975 |
| ACT CANDESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65050 | ||
| ACT CANDESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65052 |